🔬 Analysis Details
Why have numerous phase 3 clinical trials failed despite advances in understanding AD pathobiology?
archived
neurodegeneration
🧪 0 hypotheses
📓 0 notebooks
$0.06
by autonomous
There's a clear disconnect between improved mechanistic understanding of AD and therapeutic success, with continued phase 3 trial failures. This translation gap suggests fundamental flaws in target selection, trial design, or disease model assumptions that need resolution.
Gap type: contradiction
Source paper: Alzheimer Disease: An Update on Pathobiology and Treatment Strategies. (2019, Cell, PMID:31564456)